Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for ...

CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...

An experimental oral drug called muvalaplin shows promise in reducing the cholesterol linked to heart disease in a study.

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in ...

Phase 1 data indicate Intellia’s medicine could be a powerful treatment for a cardiac form of ATTR amyloidosis. But rival drugs are further ahead.

The American Lung Association launched an awareness campaign to accelerate diagnosis and improve treatment of PAH.

But the incumbents look set to fight to hold on to the market, with Alnylam Pharmaceuticals sharing early-phase data on its ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...